Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rspitale
    Junior Member
    • Jan 2013
    • 2

    #1

    Cutoffs for differential Expression analysis (DESeq and Cufflinks/Cuffdiff)

    Hey All,

    This is my first post, so please bear with me.

    I have been doing differential expression with DESeq and Cuffdiff.

    I just wondered at what level do people usually exclude genes from analysis.

    For example in DEseq, what number of raw counts do you exclude (i.e.- 10 and up, etc)?

    For Cuffdiff, what level do you cut off RPKM/FPKM. (i.e.- 1 and above use for differntial expression)?

    Also, for multiple samples do you sort all sample types by expression and remove all genes for each sample at that value?

    Sorry if this is confusing. Thanks!
  • Richard Barker
    Member
    • Apr 2012
    • 47

    #2
    For cuffdiff i normally use 10 as the minimum per-locus counts for significance testing. Hope this helps... I'm now trying to get DESeq working so can't help with that one...

    Comment

    • dpryan
      Devon Ryan
      • Jul 2011
      • 3478

      #3
      For DESeq I exclude genes with <20 counts (summed across all samples). Those are usually too few counts to calculate a meaningful statistic (see the Bourgon et al. (2010) paper in PNAS or the DESeq vignette, though I don't recall either of those giving specific recommendations for a threshold...).

      Comment

      • Richard Barker
        Member
        • Apr 2012
        • 47

        #4
        Hi dpyan
        Can you share the commands that you used for DESeq so i can see a functional example to try and guide my future attempts?

        Comment

        • dpryan
          Devon Ryan
          • Jul 2011
          • 3478

          #5
          Have a look at the "Filtering by overall count" section of the DESeq vignette, which I'll just copy and modify below:
          Code:
          rs = rowSums(counts(cdsFull))
          use = (rs > 20)
          cdsFilt = cdsFull[use,]
          The actual threshold that's best will probably vary by sample number, it's convenient to make the plot they have in the vignette as "Figure 9" so you can eyeball if the threshold is inappropriate. See also "Figure 10".

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 10:13 AM
          0 responses
          13 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          26 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          20 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          19 views
          0 reactions
          Last Post SEQadmin2  
          Working...